Brian M.
Regulatory Affairs Consultant @ Celegence
About
An accomplished technologist, scientist and regulatory writer with over 30 years contribution to the biomedical, biotechnology, biopharmaceutical and pharmaceutical fields, who possesses an exceptional aptitude to research, evaluate, translate and effectively communicate technical or complex non-clinical and clinical information and data to any audience and has provided strategy and content for many successful INDs, BLAs, NDAs (FDA and PMDA), and MAAs. Experience in small molecule (505b1 and 505b2), biologics, cell (CAR-T, NK, stem cell) and gene (iRNA, AAV, addition, editing) therapy products and devices across a very wide spectrum of therapeutic areas.
United States
Greater Philadelphia
Biotechnology
Clinical Content, Executive Advisory, Regulatory Development, Regulatory Approvals, Pharmaceutics, Team Leadership, Team Building, Clinical Development, Team Management, Research and Development/Regulatory Affairs, Medical and Regulatory Writing, IND, NDA, BLA, MAA, eCTD, Data Analysis, Regulatory Writing, German, Spanish, • Medical Communications , • Medical and Technical Writing, • Biomedical and Biotechnology Strategy , Cross-Functional/Global Relations
Experience

Senior Director (Head) Medical and Regulatory Writing/Regulatory Affairs (Medical Communications)
Newark, California, United States
RPI acquired by Premier Research and rebranded as an independent division, Premier Consulting. Manage and grow a regulatory (submissions)/medical writing service for a Regulatory Affairs consultancy. Hire and manage a team of FTE and contract regulatory writers, write and review CTD submission modules (M1, M2, M4 and M5) for INDs, BLAs, NDAs and MAAs, regulatory meeting packages, an assortment of other regulatory documents (IBs, iPSPs, PIPs, CSRs, CSPs, etc.) as well as medical communication services. Provide advice and strategy for nonclinical and clinical development (study design and presentation of results), and for regulatory submissions. Oversee the production of all CTD documents and accessory regulatory documents for small molecule (505b1 and 505b2), biologics, cell (CAR-T, NK, stem cell) and gene (iRNA, AAV, addition, editing) therapy products and devices across a very wide spectrum of therapeutic areas (Oncology, Immunology and Rheumatology, Analgesics, Dermatology, Opthalmalogy, Neurology and Mood Disorders, Gastroenterology and Metabolism, Cardiology, Women's Health, Emergency Medicine, Transplantation, Blood Disorders, Rare Disease, as well as others). Build infrastructure for efficient preparation of submission documents, set budgets, created quality controls, mentored other writers and company staff. Senior management within company structure.
Senior Director (Head) Medical and Regulatory Writing/Regulatory Affairs
Newark, California, United States
A continuation of Director role. Created a regulatory (submissions)/medical writing service for a Regulatory Affairs consultancy. Hired and managed a team of FTE and contract regulatory writers, wrote and reviewed CTD submission modules (M1, M2, M4 and M5) for INDs, BLAs, NDAs and MAAs, regulatory meeting packages, an assortment of other regulatory documents (IBs, iPSPs, PIPs, CSRs, CSPs, etc.). Provided advice and strategy for nonclinical and clinical development (study design and presentation of results), and for regulatory submissions. Oversaw the production of all CTD documents and accessory regulatory documents for small molecule (505b1 and 505b2), biologics, cell and gene therapy products and devices across a very wide spectrum of therapeutic areas (Oncology, Immunology and Rheumatology, Analgesics, Dermatology, Opthalmalogy, Neurology and Mood Disorders, Gastroenterology and Metabolism, Cardiology, Women's Health, Emergency Medicine, Transplantation, Blood Disorders, Rare Disease, as well as others). Built infrastructure for efficient preparation of submission documents, set budgets, created quality controls, mentored other writers and company staff. Senior management with company.

Contract or FTE Senior, Principal and Senior Principal Medical/Regulatory Writer
Onyx, Astellas, Merck, Otsuka, PRA, Bristol-Myers Squibb, CSLBehring
Preparation of clinical developments, regulatory and safety deliverables including: Common Technical Document (CTD and eCTD) – Submission documents: Clinical Overviews (Module 2.5) and Clinical Summaries (Module 2.7), Clinical Study Reports (Phase I to IV), Clinical Protocols, Investigator Brochures, Clinical Narratives, Drug and Periodic Safety Update Reports (DSUR/ PBRER), Risk Management Plans, Quality Assurance, proficient GCP, ICH, FDA and EMA guidance relevant to clinical and safety data. Therapeutic areas: Oncology, Neurology/Psychiatry, Vaccines, Hematology, Immunology, Cardiovascular, others. Contract assignments, completed with minimum oversight, early or on time, consistently. Manage multiple assignments simultaneously, and work in cross-functional, multicultural and international clinical trial teams. Mentor to more junior colleagues. Excellent verbal, written and presentation skills (English/Biomedical/Clinical).

Scientific Communications Lead/Strategist and Lead Medical Writer
In2itive Biomedical Solutions
Medical communications. Planned, created, edited and published biomedical, clinical, technical and educational documents. Devised medical/biomedical communication strategies. Identified and liaised with key opinion leaders, internal and external stakeholders, and influencers.
Brian M.'s Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.




